Dr Steve Worland (eFFECTOR Therapeutics)

The role of STRIs in cancer

Within cancer cells, the eIF4F complex's dysregulation amplifies the translation…

27 November 2023 | By Taylor Mixides (Drug Target Review)

Within cancer cells, the eIF4F complex's dysregulation amplifies the translation of cancer-promoting proteins, establishing it as a critical juncture in malignancy and resistance to treatment. eFFECTOR Therapeutics has responded with Selective Translation Regulator Inhibitors (STRIs). These STRIs are precision instruments dismantling the foundations of tumour growth, immune evasion, and resistance…